These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 33526768)

  • 1. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
    Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
    Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
    Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
    J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
    Huang X; Qin J; Lu S
    Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
    Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
    Chai N; Xie HH; Yin JP; Sa KD; Guo Y; Wang M; Liu J; Zhang XF; Zhang X; Yin H; Nie YZ; Wu KC; Yang AG; Zhang R
    Biochem Biophys Res Commun; 2018 Jun; 500(4):924-929. PubMed ID: 29705704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway.
    Zhang R; Gao X; Zuo J; Hu B; Yang J; Zhao J; Chen J
    Cancer Sci; 2020 Feb; 111(2):406-417. PubMed ID: 31785057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1/DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy.
    Wei T; Zeng C; Li Q; Xiao Z; Zhang L; Zhang Q; Ren L
    Cancer Sci; 2024 Sep; 115(9):3041-3053. PubMed ID: 39004911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression.
    Wu CH; Yeh CT; Lin KH
    Oncol Rep; 2020 Oct; 44(4):1686-1698. PubMed ID: 32945493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1.
    Liu YP; Pan LL; Kong CC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7335-7344. PubMed ID: 32706072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
    Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
    J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Liang SK; Hsu CC; Song HL; Huang YC; Kuo CW; Yao X; Li CC; Yang HC; Hung YL; Chao SY; Wu SC; Tsai FR; Chen JK; Liao WN; Cheng SC; Tsou TC; Wang IC
    Oncogene; 2021 Jul; 40(30):4847-4858. PubMed ID: 34155349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma.
    Tseng YH; Huang YH; Lin TK; Wu SM; Chi HC; Tsai CY; Tsai MM; Lin YH; Chang WC; Chang YT; Chen WJ; Lin KH
    Sci Rep; 2016 Dec; 6():38756. PubMed ID: 27934948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
    Li X; Yao R; Yue L; Qiu W; Qi W; Liu S; Yao Y; Liang J
    J Cell Mol Med; 2014 May; 18(5):811-23. PubMed ID: 24628949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.